Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Mucoid or highly encapsulated strains of group A streptococci have been associated both with unusually severe infections and with acute rheumatic fever. Previously, we described an acapsular mutant, TX4, derived from a mucoid M-type 18 strain of a group A streptococcus by transposon mutagenesis (M. R. Wessels, A. E. Moses, J. B. Goldberg, and T. J. DiCesare, Proc. Natl. Acad. Sci. USA 88:8317-8321, 1991). We now report studies further characterizing strain TX4 as well as an additional acapsular mutant, TX72. Strain TX4 was found to contain a 9.5-kb deletion of chromosomal DNA adjacent to the site of transposon Tn916 insertion. Cloned chromosomal DNA from TX4 flanking the transposon insertion site was used as a probe to demonstrate the presence of homologous regions in 11 of 11 wild-type group A streptococcal strains of various M protein types. A second acapsular mutant, TX72, had a single transposon insertion and had no apparent deletion of chromosomal DNA. The Tn916 insertion in TX72 was mapped to the hasA locus (encoding hyaluronate synthase), which lies within the chromosomal region deleted in TX4. Strain TX72 was avirulent in mice and sensitive to phagocytic killing in vitro. Transduction of either the insertion-deletion mutation from TX4 or the simple insertion mutation from TX72 to a type 24 group A streptococcus strain also resulted in loss of capsule expression, demonstrating that a homologous region of the chromosome controls capsule expression in another serotype of group A streptococci. We conclude that the hyaluronic acid capsule plays an important role in virulence and that a region of the chromosome essential for capsular polysaccharide expression is conserved among diverse group A streptococcal strains.
Baltimore,
Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.
1977, Pubmed
Baltimore,
Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.
1977,
Pubmed
Birnboim,
A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
1979,
Pubmed
Boulnois,
Analysis of the K1 capsule biosynthesis genes of Escherichia coli: definition of three functional regions for capsule production.
1987,
Pubmed
Caparon,
Excision and insertion of the conjugative transposon Tn916 involves a novel recombination mechanism.
1989,
Pubmed
Caparon,
Genetic manipulation of pathogenic streptococci.
1991,
Pubmed
Clewell,
Sequence analysis of termini of conjugative transposon Tn916.
1988,
Pubmed
DeAngelis,
Isolation of a Streptococcus pyogenes gene locus that directs hyaluronan biosynthesis in acapsular mutants and in heterologous bacteria.
1993,
Pubmed
Dougherty,
Molecular characterization of a locus required for hyaluronic acid capsule production in group A streptococci.
1992,
Pubmed
,
Xenbase
Dougherty,
Molecular characterization of hasB from an operon required for hyaluronic acid synthesis in group A streptococci. Demonstration of UDP-glucose dehydrogenase activity.
1993,
Pubmed
Gawron-Burke,
Regeneration of insertionally inactivated streptococcal DNA fragments after excision of transposon Tn916 in Escherichia coli: strategy for targeting and cloning of genes from gram-positive bacteria.
1984,
Pubmed
Johnson,
Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis.
1992,
Pubmed
Knutson,
A new modification of the carbazole analysis: application to heteropolysaccharides.
1968,
Pubmed
Kroll,
Common organization of chromosomal loci for production of different capsular polysaccharides in Haemophilus influenzae.
1989,
Pubmed
Kuypers,
Molecular analysis of a region of the group B streptococcus chromosome involved in type III capsule expression.
1989,
Pubmed
LANCEFIELD,
Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test.
1957,
Pubmed
O'Connor,
In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants.
1987,
Pubmed
OUCHTERLONY,
Diffusion-in-gel methods for immunological analysis.
1958,
Pubmed
Perez-Casal,
Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems.
1991,
Pubmed
Stevens,
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.
1989,
Pubmed
Vimr,
Genetic analysis of chromosomal mutations in the polysialic acid gene cluster of Escherichia coli K1.
1989,
Pubmed
WILSON,
The relative importance of the capsule and the M-antigen in determining colony form of group A streptococci.
1959,
Pubmed
Wald,
Acute rheumatic fever in western Pennsylvania and the tristate area.
1987,
Pubmed
Wessels,
Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
1991,
Pubmed
Westlake,
An outbreak of acute rheumatic fever in Tennessee.
1990,
Pubmed
Yanisch-Perron,
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.
1985,
Pubmed